Home
Search
Schedule & Agenda

Future of IO Checkpoint Combinations

[Available On-Demand]
June 8-12, 2020
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies
Panelists will feature academics and industry thought leaders as they share their expertise in novel oncology drug discovery, development and commercialization as well as address the issues related to future strategies for unlocking the potential of checkpoint inhibitors, including the failure of some first generation targets and what new approaches might look like.
Moderator
photo
Jeffrey Bockman, PhD
EVP, Oncology Practice Head
Cello Health BioConsulting (Previously Defined Health)
Speakers
photo
Jeffrey Bockman, PhD
EVP, Oncology Practice Head
Cello Health BioConsulting (Previously Defined Health)
photo
Michael Curran
Associate Professor, Department of Immunology
MD Anderson Cancer Center
photo
John Engelhardt
Director, Immuno-Oncology Discovery
Bristol Myers Squibb
photo
Denise Faustman
Head of Immunobiology Lab
Massachusetts General Hospital
photo
Axel Hoos
Senior Vice President and Therapeutic Area Head Oncology
GlaxoSmithKline
photo
Peter Sandor, MD
Senior Vice President
Astellas